Suppr超能文献

抗寄生虫药

Antiparasitic agents.

作者信息

Rosenblatt J E

机构信息

Division of Infectious Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905.

出版信息

Mayo Clin Proc. 1992 Mar;67(3):276-87. doi: 10.1016/s0025-6196(12)60105-0.

Abstract

In recent years, introduction of new and more effective agents has improved the overall therapy for parasitic infections. This field, however, is still plagued by numerous problems, including the development of resistance to antimicrobial agents (especially with malaria), unavailability of agents in the United States or lack of approval by the Food and Drug Administration, and major toxicities or lack of experience in pregnant women and children, which limits use in these groups of patients. Widespread resistance of Plasmodium falciparum to chloroquine and other agents has complicated the treatment and prophylaxis of this type of malaria. A combination of quinine and Fansidar is usually effective oral therapy for falciparum malaria; quinidine may be administered if intravenous therapy is needed. Mefloquine, which is currently recommended for prophylaxis against chloroquine-resistant P. falciparum, is also effective for single-dose oral treatment, although this regimen has not yet been approved by the Food and Drug Administration. Metronidazole has been widely used for treatment of gastroenteritis due to Entamoeba histolytica and Giardia lamblia (not approved by the Food and Drug Administration for the latter) and is considered safe and effective. A new macrolide, azithromycin, has been reported to be effective for cryptosporidiosis in experimental animals; currently, no effective therapy is available for human infections. Combinations of sulfonamides with other antifolates, trimethoprim or pyrimethamine, are recommended therapy for Pneumocystis carinii pneumonia or toxoplasmosis, respectively. Therapies for the various types of leishmaniasis and trypanosomiasis are complex, often toxic, and often of limited efficacy. The benzimidazoles are effective for roundworm infections, although thiabendazole has severe toxic effects. The recent introduction of ivermectin has revolutionized the treatment and control of onchocerciasis. Another relatively new agent, praziquantel, is a true broad-spectrum anthelmintic agent that is effective against most trematodes, many adult cestodes, and larval cestodes as well (especially cysticerci of Taenia solium).

摘要

近年来,新型且更有效的药物的引入改善了寄生虫感染的整体治疗方法。然而,该领域仍然存在诸多问题,包括对抗菌药物产生耐药性(尤其是疟疾)、在美国无法获得某些药物或未获美国食品药品监督管理局批准、以及存在严重毒性或缺乏针对孕妇和儿童的用药经验,这些都限制了这些药物在这类患者群体中的使用。恶性疟原虫对氯喹和其他药物的广泛耐药性使这种疟疾的治疗和预防变得复杂。奎宁和 Fansidar 的联合用药通常是治疗恶性疟疾有效的口服疗法;若需要静脉治疗,可使用奎尼丁。甲氟喹目前被推荐用于预防对氯喹耐药的恶性疟原虫,单剂量口服治疗也有效,尽管该疗法尚未获美国食品药品监督管理局批准。甲硝唑已广泛用于治疗由溶组织内阿米巴和蓝氏贾第鞭毛虫引起的肠胃炎(后者未获美国食品药品监督管理局批准),且被认为安全有效。据报道,一种新型大环内酯类药物阿奇霉素在实验动物中对隐孢子虫病有效;目前,人类感染尚无有效治疗方法。磺胺类药物与其他抗叶酸剂(分别为甲氧苄啶或乙胺嘧啶)联合用药,分别是治疗卡氏肺孢子虫肺炎或弓形虫病的推荐疗法。治疗各种类型利什曼病和锥虫病的方法复杂,通常有毒性,且疗效往往有限。苯并咪唑类药物对蛔虫感染有效,尽管噻苯达唑有严重的毒性作用。伊维菌素的近期引入彻底改变了盘尾丝虫病的治疗和控制。另一种相对较新的药物吡喹酮是一种真正的广谱驱虫剂,对大多数吸虫、许多成虫绦虫以及幼虫绦虫(尤其是猪带绦虫囊尾蚴)均有效。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验